No profile data available.
Corbus Pharmaceuticals Holdings, Inc. (CRBP) is a healthcare company in the additional cancer treatment drugs industry, based in Norwood, United States, with about 28 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$78.54 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $0. Its market capitalization was $187.64 million as of December 4, 2025.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of December 4, 2025.
, a biopharmaceutical company, develops products to defeat serious illness.
Corbus Pharmaceuticals reported $0 in revenue for fiscal year 2025. In Q2 2026 revenue was $0.
$187.64 million as of December 4, 2025.
Listed companies of a similar size in the same industry (additional cancer treatment drugs) include Sutro Biopharma, Inc. (STRO), Compugen Ltd. (CGEN), Whitehawk Therapeutics, Inc. (WHWK), Adagene Inc. (ADAG).